Skip to content

FP7HORIZONH2020

Region Skane

Country
SESweden
Defence projects
0
Projects, all programmes
29
As coordinator
1
EU contribution (CORDIS)
EUR 8,388,750
Active
2009 to 2025

Projects

29 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
REALCHEMReal-world emission Experiments and comprehensive Assessment of Low-carbon fuels: towards Clean Hard-to-Electrify traffic ModesHORIZON2025ParticipantEUR 56,250
EU-CIPEUropean Cancer Information PortalHORIZON2025ParticipantEUR 190,000
ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCEHORIZON2024ParticipantEUR 18,938
ARCADIATrAnsformative climate ResilienCe by nAture-baseD solutions in the contInentAl bio-geographical regionHORIZON2024Associated partnerEUR 0
Invest4HealthMobilising novel finance models for health promotion and disease preventionHORIZON2023CoordinatorEUR 487,938
PREPAREAn EU-wide springboard for regional implementation of innovation procurementHORIZON2023ParticipantEUR 90,625
Maxima ButterflyFrom Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology networkHORIZON2023Associated partnerEUR 0
CCI4EUCOMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPEHORIZON2023Third partyNot stated
PRIME-ROSEPRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical TrialsHORIZON2023Associated partnerEUR 0
Procure4HealthHealthcare Innovation Procurement NetworkHORIZON2022Third partyNot stated
Carematrix PCPPre-commercial procurement for integrated CARE solutions addressing the Multimorbidity mATRIX in ageing populationsH20202021ParticipantEUR 4,043,797
INNODIA HARVESTTranslational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIAH20202020Third partyNot stated
HEDIMEDHuman Exposomic Determinants of Immune Mediated DiseasesH20202020Third partyNot stated
iLIVELiving well, dying well. A research programme to support living until the endH20202019Third partyNot stated
SYNDEGENSynaptic dysfunction in Neurodegenerative DiseasesH20202017PartnerEUR 0
TreatERClinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug deliveryH20202017ParticipantEUR 716,395
PAPA-ARTISParaplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre TrialH20202017ParticipantEUR 221,303
INNODIATranslational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797H20202015Third partyNot stated
BIOCYCLEBIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s diseaseH20202015ParticipantEUR 293,133
READI FOR HEALTHRegional Digital Agendas for HealthcareFP72013ParticipantEUR 605,155

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.